Download | < Back |
13 Feb 2021 | |
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the following:<BR> 1) Standalone Unaudited Financial Results of the Company for the Quarter ended on 31st December, 2020.<BR> <BR> 2) Limited Review Report by Statutory Auditors on Standalone Unaudited Financial Results for the quarter ended on 31st December, 2020<BR> | |
View all announcements for NORRIS MEDICINES LTD. | Source: BSE India |